{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:38:53Z","timestamp":1791689933838,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008436","name":"Ernst und Berta Grimmke Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.exer.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T15:15:22Z","timestamp":1397574922000},"page":"72-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["A TGF-\u03b2 receptor 1 inhibitor for prevention of proliferative vitreoretinopathy"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-3828","authenticated-orcid":false,"given":"Khaled","family":"Nassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaantje","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Tura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"L\u00fcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nprot.2007.4","article-title":"In\u00a0vivo models of proliferative vitreoretinopathy","volume":"2","author":"Agrawal","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ophtha.2008.05.016","article-title":"Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial","volume":"115","author":"Ahmadieh","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2014.04.006_bib3","first-page":"522","article-title":"Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy","volume":"34","author":"Araiz","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/bjophthalmol-2011-300139","article-title":"Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseases","volume":"95","author":"Asato","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib5","series-title":"Intraocular Drug Delivery","first-page":"11","article-title":"Retinal drug delivery","author":"Ashton","year":"2006"},{"key":"10.1016\/j.exer.2014.04.006_bib6","series-title":"Principles of Toxicology Testing","author":"Barile","year":"2007"},{"key":"10.1016\/j.exer.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0161-6420(84)34318-4","article-title":"5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite","volume":"91","author":"Blumenkranz","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2014.04.006_bib8","first-page":"2336","article-title":"TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy","volume":"41","author":"Bochaton-Piallat","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/08977199009037500","article-title":"Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3","volume":"3","author":"Brown","year":"1990","journal-title":"Growth Factors"},{"key":"10.1016\/j.exer.2014.04.006_bib11","series-title":"Immunohistochemistry: Basics and Methods","author":"Buchwalow","year":"2010"},{"key":"10.1016\/j.exer.2014.04.006_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2008.08.002","article-title":"Epithelial phenotype and the RPE: Is the answer blowing in the Wnt?","volume":"27","author":"Burke","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bjo.2003.039917","article-title":"An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy","volume":"88","author":"Cardillo","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0161-6420(97)30167-5","article-title":"Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome","volume":"104","author":"Cardillo","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajo.2008.05.002","article-title":"Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy","volume":"146","author":"Chang","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib16","first-page":"95","article-title":"Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells","volume":"14","author":"Cheng","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bjo.64.11.801","article-title":"Experimental posterior penetrating eye injury in the rhesus monkey: vitreous-lens admixture","volume":"64","author":"Cleary","year":"1980","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bjo.63.5.306","article-title":"Experimental posterior penetrating eye injury in the rabbit. I. Method of production and natural history","volume":"63","author":"Cleary","year":"1979","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bjo.63.5.312","article-title":"Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina","volume":"63","author":"Cleary","year":"1979","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1172\/JCI114065","article-title":"Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye","volume":"83","author":"Connor","year":"1989","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.exer.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1167\/iovs.04-0643","article-title":"High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy","volume":"45","author":"Dieudonn\u00e9","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0042-6989(81)90149-8","article-title":"The isolation and culturing of retinal pigment epithelium of the rat","volume":"21","author":"Edwards","year":"1981","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2008.08.013","article-title":"Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors","volume":"132","author":"Fretz","year":"2008","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.exer.2014.04.006_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00006982-200312000-00004","article-title":"Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy","volume":"23","author":"Furino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.exer.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2407-11-59","article-title":"SFRP1 reduction results in an increased sensitivity to TGF-\u03b2 signaling","volume":"11","author":"Gauger","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exer.2014.04.006_bib26","first-page":"391","article-title":"Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype","volume":"36","author":"Grisanti","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib27","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/0008-5472.CAN-12-0546","article-title":"Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-\u03b2","volume":"72","author":"Hardee","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1167\/iovs.03-1330","article-title":"The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes","volume":"45","author":"Hirayama","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bjophthalmol-2012-302636","article-title":"Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment","volume":"97","author":"Hoerster","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.exer.2006.10.017","article-title":"Inhibition of RhoA\/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells","volume":"84","author":"Itoh","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy","volume":"84","author":"Jonas","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib32","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.0611660104","article-title":"Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling","volume":"104","author":"Kano","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.exer.2014.04.006_bib33","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db08-0302","article-title":"Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins","volume":"57","author":"Kawahara","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2014.04.006_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.mcn.2009.10.008","article-title":"An in\u00a0vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury","volume":"43","author":"Kimura-Kuroda","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.exer.2014.04.006_bib35","doi-asserted-by":"crossref","first-page":"17504","DOI":"10.1073\/pnas.0804054105","article-title":"Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target","volume":"105","author":"Kita","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.exer.2014.04.006_bib36","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2337\/db06-1644","article-title":"Functional characteristics of connective tissue growth factor on vitreoretinal cells","volume":"56","author":"Kita","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2014.04.006_bib37","first-page":"705","article-title":"Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study","volume":"40","author":"Kon","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9394(75)90390-6","article-title":"Glial cell proliferation in retinal detachment (massive periretinal proliferation)","volume":"80","author":"Laqua","year":"1975","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib39","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1167\/iovs.07-0086","article-title":"The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy","volume":"48","author":"Lee","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib40","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/jm058209g","article-title":"Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7","volume":"49","author":"Li","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.exer.2014.04.006_bib41","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1111\/j.1755-3768.2011.02147.x","article-title":"Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy","volume":"89","author":"Liang","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/02713689409025133","article-title":"Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy","volume":"13","author":"Limb","year":"1994","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib43","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3109\/02713683.2010.512408","article-title":"The effect of adjuvant dimethylenastron, a mitotic Kinesin Eg5 inhibitor, in experimental glaucoma filtration surgery","volume":"35","author":"L\u00fcke","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"Pt 2","key":"10.1016\/j.exer.2014.04.006_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/eye.1987.46","article-title":"Age-related cellular proliferation at the vitreoretinal juncture","volume":"1","author":"McLeod","year":"1987","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.exer.2014.04.006_bib46","series-title":"Methods in Molecular Medicine","first-page":"111","article-title":"Cell cultures of autopsy-derived fibroblasts","volume":"Vol. 107","author":"Meske","year":"2005"},{"key":"10.1016\/j.exer.2014.04.006_bib47","first-page":"553","article-title":"Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"8","author":"Nakamuta","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2014.04.006_bib48","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00417-011-1730-9","article-title":"The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)","volume":"249","author":"Nassar","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib49","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1167\/iovs.09-3621","article-title":"Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells","volume":"50","author":"Parapuram","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib50","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/bi048851x","article-title":"Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition","volume":"44","author":"Peng","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.exer.2014.04.006_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/exer.1994.1114","article-title":"Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye","volume":"59","author":"Pfeffer","year":"1994","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib52","series-title":"ImageJ","author":"Rasband","year":"2011"},{"key":"10.1016\/j.exer.2014.04.006_bib53","series-title":"JMicroVision: Image Analysis Toolbox for Measuring and Quantifying Components of High-definition Images","author":"Roduit","year":"2011"},{"key":"10.1016\/j.exer.2014.04.006_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)75004-4","article-title":"The pathophysiology of proliferative vitreoretinopathy in its management","volume":"100","author":"Ryan","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20110086","article-title":"TGF-\u03b2\/TGF-\u03b2 receptor system and its role in physiological and pathological conditions","volume":"121","author":"Santiba\u00f1ez","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2014.04.006_bib56","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1021\/jm0205705","article-title":"Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain","volume":"46","author":"Sawyer","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.exer.2014.04.006_bib57","series-title":"Ophthalmic Pathology: An Illustrated Guide for Clinicians","author":"Sehu","year":"2005"},{"key":"10.1016\/j.exer.2014.04.006_bib58","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1167\/iovs.11-7587","article-title":"Role of TGFbeta\/Smad signaling in gremlin induction of human trabecular meshwork extracellular matrix proteins","volume":"52","author":"Sethi","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib59","doi-asserted-by":"crossref","first-page":"33971","DOI":"10.1074\/jbc.M607010200","article-title":"Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta","volume":"281","author":"Shiou","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.exer.2014.04.006_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2012.03.006","article-title":"Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea","volume":"98","author":"Singh","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib61","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nprot.2009.33","article-title":"A\u00a0protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells","volume":"4","author":"Sonoda","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2014.04.006_bib62","first-page":"CD006421","article-title":"Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery","volume":"1","author":"Sundaram","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2014.04.006_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ki.2011.464","article-title":"Transforming growth factor-\u03b2 induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction","volume":"81","author":"Suzuki","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.exer.2014.04.006_bib64","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1167\/iovs.09-4725","article-title":"Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact","volume":"51","author":"Tamiya","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib65","doi-asserted-by":"crossref","first-page":"e69994","DOI":"10.1371\/journal.pone.0069994","article-title":"TNF-\u03b1 decreases VEGF secretion in highly polarized RPE cells but increases it in non-polarized RPE cells related to crosstalk between JNK and NF-\u03baB pathways","volume":"8","author":"Terasaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2014.04.006_bib66","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1167\/iovs.06-1271","article-title":"The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in\u00a0vitro","volume":"48","author":"Tura","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib67","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2012.11.054","article-title":"Protective effects of TGF-\u03b2 inhibitors in a rat model of NMDA-induced retinal degeneration","volume":"699","author":"Ueda","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2014.04.006_bib68","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0014-4835(89)80030-2","article-title":"Posterior penetrating injury in the rabbit eye: effect of blood and ferrous ions","volume":"49","author":"Vergara","year":"1989","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2014.04.006_bib69","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.cellsig.2011.06.019","article-title":"The specificities of small molecule inhibitors of the TGF\u00df and BMP pathways","volume":"23","author":"Vogt","year":"2011","journal-title":"Cell. Signal"},{"key":"10.1016\/j.exer.2014.04.006_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00154210","article-title":"Proliferative vitreoretinopathy\u2013is it anything more than wound healing at the wrong place?","volume":"14","author":"Weller","year":"1990","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00170548","article-title":"Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy","volume":"229","author":"Wiedemann","year":"1991","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib72","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00184858","article-title":"Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?","volume":"234","author":"Williams","year":"1996","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib73","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5301\/EJO.2010.6067","article-title":"TGF-\u00df and RPE-derived cells in taut subretinal strands from patients with proliferative vitreoretinopathy","volume":"21","author":"Winkler","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.exer.2014.04.006_bib75","doi-asserted-by":"crossref","first-page":"F1705","DOI":"10.1152\/ajprenal.00043.2008","article-title":"High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells","volume":"295","author":"Xia","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.exer.2014.04.006_bib76","doi-asserted-by":"crossref","first-page":"e40301","DOI":"10.1371\/journal.pone.0040301","article-title":"A\u00a0new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2014.04.006_bib77","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00417-008-0829-0","article-title":"One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy","volume":"246","author":"Yamakiri","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.04.006_bib78","first-page":"1975","article-title":"The involvement of polyamines in the proliferation of cultured retinal pigment epithelial cells","volume":"37","author":"Yanagihara","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.04.006_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00417-011-1766-x","article-title":"The PI3K\/Akt pathway mediates the expression of type I collagen induced by TGF-\u03b22 in human retinal pigment epithelial cells","volume":"250","author":"Yokoyama","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:56:33Z","timestamp":1757998593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483514000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":79,"alternative-id":["S0014483514000943"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2014.04.006","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A TGF-\u03b2 receptor 1 inhibitor for prevention of proliferative vitreoretinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}